Chemists at a drug discovery incubator are responsible for purifying and properly characterizing the new chemicals. When the agency identifies an in vitro hit, it turns to the chemist for determining the analogous compounds for evaluating the Structure-Activity Relationships (SARs). This is crucial for optimizing the desired activity shown by the Hit compound. Expert chemists at integrated drug discovery agencies gain significant knowledge about a target disease and the relevant competitive therapeutics.
Article source: https://integralbiosciences.com/blog/drug-discovery-services-and-medicinal-chemistry-an-evolving-bond